Effects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study

Journal of the American Society of Nephrology

Volumn 14, Issue 12, 2003, Pages 3251-3263

  Cheung, Alfred K ^a   Levin, Nathan W ^b   Greene, Tom ^c   Agodoa, Lawrence ^d   Bailey, James ^e   Beck, Gerald ^c   Clark, William ^f   Levey, Andrew S ^g   Leypoldt, John K ^a   Ornt, Daniel B ^h   Rocco, Michael V ⁱ   Schulman, Gerald ^j   Schwab, Steve ^k   Teehan, Brendan ^l   Eknoyan, Garabed ^m  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Baxter Corporation   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l LANKENAU HOSPITAL   (United States)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART OUTPUT; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT;

EID: 0345098607     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000096373.13406.94     Document Type: Article

References (35)

1. United States Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, 2002
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, HEMO Study Group: Effect of dialysis dose and membrane flux on mortality and morbidity in maintenance hemodialysis patients: Primary results of the HEMO study. N Engl J Med 347: 2010-2019, 2002
3. 2-microglobulin. J Am Soc Nephrol 10: 117-127, 1999
4. Murthy BVR, Sundaram S, Jaber BL, Perrella C, Meyer KB, Pereira BJG: Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. J Am Soc Nephrol 9: 464-472, 1998
5. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study. Kidney Int 39: 320-327, 1991
6. Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3: 1409-1415, 1993
7. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis: The Working Party on Dialysis Amyloidosis. Kidney Int 39: 1012-1019, 1991
8. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52: 1096-1101, 1997
9. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with highflux dialysis. J Am Soc Nephrol 3: 1227-1237, 1992
10. Woods HF, Nandakumar M: Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 15[Suppl]: 36-42, 2000
11. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 37: 276-286, 2001
12. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46: 830-837, 1994
13. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47: 573-578, 1995
14. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol Dial Transplant 7: 16-28, 1992
15. Lonnemann G, Sereni L, Lemke HD, Tetta C: Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. Artif Organs 25: 951-960, 2001
16. Leypoldt JK, Cheung AK, Deeter RB: Single compartment models for evaluating β2-microglobulin clearance during hemodialysis. ASAIO J 43: 904-909, 1997
17. Daugirdas JT, Greene T, Depner TA, Chumlea C, Rocco MJ, Chertow GM, Hemodialysis (HEMO) Study Group: Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender. Kidney Int 64: 1108-1119, 2003
18. Depner TA, Greene T, Daugirdas JT, Cheung AK, Gotch FA, Leypoldt JK, HEMO Study Group: Dialyzer performance in the HEMO Study: In vivo KoA and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO J 2004, in press
19. Cox DR: Regression models and life tables. J R Star Soc Ser B 34: 187-220, 1972
20. Miskulin DC, Athienites NV, Yan G, Martin AA, Omt DB, Kusek JW, Meyer KB, Levey AS, Hemodialysis (HEMO) Study Group: Comorbidity assessment using the index of coexistent disease in a multicenter clinical trial study. Kidney Int 60: 1498-1510, 2001
21. McCullagh P, Nelder JA: Monographs on Statistics and Applied Probability: Generalized Linear Models, London, Chapman & Hall, 1989
22. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in end stage renal disease patients on convective and diffusive extracorporeal treatments: The Registro Lombardo Dialisi e Trapianto. Kidney Int 55: 286-293, 1999
23. Bloembergen WE, Hakim RM, Stannard DC, Held PJ, Wolfe RA, Agodoa LY, Port FK: Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33: 1-10, 1999
24. Horl WH, Haag-Weber M, Georgopoulos A, Block LH: Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 87: 6353-6357, 1990
25. Cohen G, Haag-Weber M, Mai B, Deicher R, Horl WH: Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 6: 1592-1599, 1995
26. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
27. Lindsay RM, Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13: 382-389, 1989
28. Marcus RG, Cohl E, Uribarri J: Middle molecule clearance does not influence protein intake in hemodialysis patients. Am J Kidney Dis 31: 491-494, 1998
29. Anderstam B, Mamoun AH, Sodersten P, Bergstrom J: Middlesized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 7: 2453-2460, 1996
30. Johansen KL, Mulligan K, Tai V, Schambelan M: Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 9: 1080-1084, 1998
31. Bergstrom J: Mechanisms of uremic suppression of appetite. J Ren Nutr 9: 129-132, 1999
32. Navarro JF, Marcen R, Teruel JL, Martin del Rio R, Gamez C, Mora C, Ortuno J: Effect of different membranes on amino-acid losses during haemodialysis. Nephrol Dial Transplant 13: 113-117, 1998
33. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW: Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61: 2240-2249, 2002
34. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Levin NW, HEMO Group: Levels of α1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int 60: 2360-2366, 2001
35. Ebben J, Liu J, Collins A: Membrane associated mortality in incident and prevalent hemodialysis patients. J Am Soc Nephrol 13: 614A, 2002